|
| Exchange Disseminated Time | Mangalam Drugs & Organics Ltd has informed BSE that The Independent Directors at their seperate Meeting held on March 30, 2016 at the registered office of the Company, inter-alia transacted the following business:
1. Reviewed the performance of non-independent directors and the Board as a Whole;.
2. Reviewed the performance of the Chairperson of the Company, taking into account the views of executive directors and non-executive directors.
3. Assessed the quality, quantity and timeliness of flow of Information between the Company management and the Board that is necessary for the Board to effectively and reasonably perform their duties. |
|
|